Antiretroviral agent (R)-9-(2-phosphonomethoxypropyl)adenine stimulates cytokine and nitric oxide production

This publication has 41 references indexed in Scilit:

• Antiviral efficacy of PMPA in macaques chronically infected with SIV
  Antiviral Research, 1996
• Anti-HIV Potential of a New Interferon, Interferon-τ (Trophoblastin)
  JAIDS Journal of Acquired Immune Deficiency Syndromes, 1996
• Activity of the (R)-Enantiomers of 9-(2-Phosphonylmethoxypropyl)-Adenine and 9-(2-Phosphonylmethoxypropyl)-2,6-diaminopurine against Human Immunodeficiency Virus in Different Human Cell Systems
  Biochemical and Biophysical Research Communications, 1996
• An elusive soluble suppressor
  Nature, 1995
• A randomized, double-blind, placebo-controlled phase I/II evaluation of 9-[2-(bispivaloyloxy-methyl) phosphonyl-methoxy]adenine (bis-POM PMEA), an orally bioavailable prodrug of the anti-HIV nucleotide, PMEA
  Antiviral Research, 1995
• Synthesis of Enantiomeric N-(2-Phosphonomethoxypropyl) Derivatives of Purine and Pyrimidine Bases. I. The Stepwise Approach
  Collection of Czechoslovak Chemical Communications, 1995
• Two inhibitors of pro‐inflammatory cytokine release, interleukin‐10 and interleukin‐4, have contrasting effects on release of soluble p75 tumor necrosis factor receptor by cultured monocytes
  European Journal of Immunology, 1994
• Induction of macrophage nitric oxide production by interferon‐γ and tumor necrosis factor‐α is enhanced by interleukin‐10
  European Journal of Immunology, 1993
• Use of two virustatica (AZT, PMEA) in the treatment of FIV and of FeLV seropositive cats with clinical symptoms
  Veterinary Immunology and Immunopathology, 1992
• Activity of acyclic nucleoside phosphonate analogues against human immunodeficiency virus in monocyte/macrophages and peripheral blood lymphocytes
  Biochemical and Biophysical Research Communications, 1991